Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24
Chemed (NYSE: CHE) has scheduled its first-quarter 2025 earnings release for April 23, 2025, after the NYSE trading closes. The company will host a conference call and webcast on April 24, 2025, at 10 a.m. ET to discuss quarterly results and provide a business update.
Participants can access the event through Chemed's investor relations website or via teleconference registration. A replay will be available approximately two hours after the call through the company's website.
Chemed operates two main subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States.
Chemed (NYSE: CHE) ha programmato la pubblicazione dei risultati del primo trimestre 2025 per il 23 aprile 2025, dopo la chiusura delle contrattazioni NYSE. L'azienda ospiterà una teleconferenza e una diretta web il 24 aprile 2025, alle 10:00 ET, per discutere i risultati trimestrali e fornire un aggiornamento sull'attività.
I partecipanti possono accedere all'evento tramite il sito web delle relazioni con gli investitori di Chemed o registrandosi per la teleconferenza. Una registrazione sarà disponibile circa due ore dopo la chiamata sul sito web dell'azienda.
Chemed gestisce due principali filiali: VITAS Healthcare, il più grande fornitore nazionale di assistenza hospice per la fine della vita, e Roto-Rooter, il principale fornitore di servizi di idraulica e pulizia delle fognature negli Stati Uniti.
Chemed (NYSE: CHE) ha programado la publicación de sus resultados del primer trimestre de 2025 para el 23 de abril de 2025, después del cierre de la negociación en la NYSE. La compañía llevará a cabo una conferencia telefónica y una transmisión web el 24 de abril de 2025, a las 10 a.m. ET, para discutir los resultados trimestrales y proporcionar una actualización del negocio.
Los participantes pueden acceder al evento a través del sitio web de relaciones con inversores de Chemed o mediante el registro para la teleconferencia. Una repetición estará disponible aproximadamente dos horas después de la llamada a través del sitio web de la empresa.
Chemed opera dos subsidiarias principales: VITAS Healthcare, el proveedor más grande del país de atención hospice al final de la vida, y Roto-Rooter, el principal proveedor de servicios de fontanería y limpieza de desagües en los Estados Unidos.
Chemed (NYSE: CHE)는 2025년 1분기 실적 발표를 2025년 4월 23일, NYSE 거래 종료 후로 예정하고 있습니다. 회사는 2025년 4월 24일 오전 10시 ET에 분기 실적을 논의하고 사업 업데이트를 제공하기 위해 전화 회의 및 웹캐스트를 개최할 것입니다.
참가자는 Chemed의 투자자 관계 웹사이트를 통해 또는 전화 회의 등록을 통해 이벤트에 접근할 수 있습니다. 통화 후 약 2시간 후에 회사 웹사이트를 통해 재생이 가능할 것입니다.
Chemed는 두 개의 주요 자회사를 운영하고 있습니다: VITAS Healthcare, 미국에서 가장 큰 생애 말기 호스피스 제공업체, 그리고 Roto-Rooter, 미국에서 선도적인 배관 및 배수 청소 서비스 제공업체입니다.
Chemed (NYSE: CHE) a programmé la publication de ses résultats pour le premier trimestre 2025 le 23 avril 2025, après la fermeture des échanges à la NYSE. L'entreprise organisera une conférence téléphonique et un webinaire le 24 avril 2025 à 10h00 ET pour discuter des résultats trimestriels et fournir une mise à jour sur l'activité.
Les participants peuvent accéder à l'événement via le site web des relations investisseurs de Chemed ou en s'inscrivant à la téléconférence. Un enregistrement sera disponible environ deux heures après l'appel sur le site web de l'entreprise.
Chemed exploite deux principales filiales : VITAS Healthcare, le plus grand fournisseur national de soins hospice en fin de vie, et Roto-Rooter, le principal fournisseur de services de plomberie et de nettoyage des drains aux États-Unis.
Chemed (NYSE: CHE) hat die Veröffentlichung der Ergebnisse für das erste Quartal 2025 auf den 23. April 2025 nach Börsenschluss der NYSE angesetzt. Das Unternehmen wird am 24. April 2025 um 10 Uhr ET eine Telefonkonferenz und ein Webcast abhalten, um die Quartalsergebnisse zu besprechen und ein Update zum Geschäft zu geben.
Teilnehmer können über die Investor-Relations-Website von Chemed oder durch die Registrierung zur Telefonkonferenz auf die Veranstaltung zugreifen. Eine Wiederholung wird etwa zwei Stunden nach dem Anruf über die Website des Unternehmens verfügbar sein.
Chemed betreibt zwei Hauptgesellschaften: VITAS Healthcare, den größten Anbieter von Hospizpflege am Lebensende im Land, und Roto-Rooter, den führenden Anbieter von Sanitär- und Abflussreinigungsdiensten in den Vereinigten Staaten.
- None.
- None.
Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, April 24, 2025, to discuss the company's quarterly results and to provide an update on its business.
Participants may access a live webcast of the conference call through the investor relations section of Chemed’s website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/ey8mpmti.
Participants may also register via teleconference at: https://register-conf.media-server.com/register/BI7c94b6cdd2574c8a8508d7a5a1235973.
Once registration is completed, participants will be provided with a dial-in number containing a personalized conference code to access the call. All participants are instructed to dial-in 15 minutes prior to the start time.
A taped replay of the conference call will be available beginning approximately two hours after the call's conclusion. You may access the replay via webcast through the investor relations section of Chemed’s website.
Listed on the New York Stock Exchange and headquartered in
Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250401675847/en/
Michael D. Witzeman
(513) 762-6714
Source: Chemed Corporation